Ajax Therapeutics
New York, NY
Ajax is targeting hematologic malignancies with greater precision by applying state-of-the-art computational chemistry and structural biology throughout the drug discovery and development process to create best-in-class therapies for significant unmet medical needs.
ajaxtherapeutics.comCompany Details
Founded
- 2019
Employees
- Between 5 - 20 employees
Raised
- $143,000,000
Headquarters Location
- New York, NY
Public
- No
Acquired
- No
CEO
Martin Vogelbaum
Founders
- Martin Vogelbaum
Company Collections
These are collections Ajax Therapeutics is a part of. Click on the collection name to view similar companies.
Ajax Therapeutics' Industries
Ajax Therapeutics Headquarters Location
275 Madison Ave 39th Floor, New York, NY 10016
Total Amount Raised: $143,000,000
Ajax Therapeutics Funding Rounds
Series C
$95,000,000
Series C Investors
Goldman Sachs Asset ManagementSchrodingerPoint72 VenturesEli Lilly and Company FoundationInning One VenturesBoxer CapitalRA Capital ManagementVivo CapitalEcoR1 CapitalSeries Unknown
$40,000,000
Series Unknown Investors
EcoR1 CapitalMemorial Sloan Kettering Cancer CenterBoxer CapitalInning One VenturesSchrodingerNYU Langone Medical CenterSeries Unknown
$8,000,000
Funding info provided by Diffbot.
Ajax Therapeutics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Ajax Therapeutics.